U.S. Metals and Mining Stock News

AMN Healthcare Services has surged 118.7% year to date, yet its broader valuation checks and mixed signals from different methods suggest the stock may no longer be an obvious bargain at current levels. The stock is up 118.7% year to date, which puts extra attention on whether recent gains already reflect most of the value in the business. Interest in AI driven healthcare staffing solutions highlighted by Ardian's investment in Pflegia can support sentiment toward AMN Healthcare Services,...

POET Technologies stock has delivered an 86.7% gain over the past three years, yet its broader valuation checks currently lean expensive, creating a clear tension between past returns and present pricing. Over three years, POET Technologies has returned 86.7%, which puts recent short term share price weakness into the context of a strong longer run. Expectations around POET Technologies’ role in AI related photonics and its recent supply agreements can support higher growth assumptions,...

Wolfspeed stock has retreated sharply over the past month, yet valuation checks still point to a company that screens as expensive rather than a clear bargain. The share price is down about 46.9% over the past month, which has taken some heat out of the rally but has not flipped the story into obvious value territory. Expectations for Wolfspeed's future revenue growth in wide bandgap semiconductors can support a premium, but ongoing investment needs and execution risk around scaling...

Genuine Parts stock has delivered a roughly 15% decline over the past three years, yet current valuation checks suggest a mixed picture rather than a clear bargain or a clear premium after the recent earnings related pullback. Over the past three years, Genuine Parts has declined about 15%, which puts recent price action in the context of a stock that has struggled to generate positive medium term returns. Planned separation of the automotive and industrial businesses may support future...

CRISPR Therapeutics stock has delivered a steep decline of around 60% over the past five years, yet current valuation checks suggest the shares now sit closer to “about right” than clearly cheap or clearly expensive. The roughly 60.1% share price fall over five years raises the question of whether past optimism was too high or whether the market has now become overly cautious on CRISPR Therapeutics. Future value can be heavily influenced by how effectively CRISPR Therapeutics turns its gene...

Royal Caribbean Cruises (RCL) is back in focus after appointing Tara Bunch, a veteran operations leader from Airbnb, Apple and Hewlett-Packard, to its Board, as investors weigh valuation signals and upcoming earnings. See our latest analysis for Royal Caribbean Cruises. Royal Caribbean Cruises shares have eased in the short term, with a 7 day share price return of 3.59% and 30 day share price return of 8.44% from the recent high. However, a 90 day share price return of 6.61% and a 5 year...

In recent days, Silicon Motion Technology has attracted increased attention after analysts significantly raised their earnings estimates and the stock received a top Zacks Rank #1 (Strong Buy) rating, signaling upgraded expectations for its near-term financial performance. This shift in analyst sentiment highlights how improving profit forecasts and external validation can quickly reshape market perceptions of Silicon Motion’s earnings potential. With these upgraded earnings estimates now in...

Globalstar (GSAT) has caught investor attention after recent trading, with the stock showing a year to date gain of 23.75%, alongside a reported annual revenue of $283.02 million and a net loss of $19.35 million. See our latest analysis for Globalstar. While the 1 day and 90 day share price returns for Globalstar are slightly negative, the year to date share price return of 23.75% alongside a very large 1 year total shareholder return of 217.65% suggests momentum has been strong over a longer...

W. R. Berkley (WRB) stock is in focus after the insurer reported stronger than expected Q2 2026 operating income and record net investment income, along with year over year gains in revenue and net income. See our latest analysis for W. R. Berkley. The earnings surprise and record investment income appear to be feeding into stronger momentum for W. R. Berkley, with a 1-day share price return of 1.48%, a 30-day share price return of 6.48%, and a 5-year total shareholder return of 153.06%, all...

Tempus AI has agreed to acquire Personalis (NasdaqGM:PSNL) in a definitive transaction. Following the deal announcement, Monteverde & Associates launched an investigation into the fairness of the transaction terms for Personalis shareholders. Personalis enters this acquisition agreement with Tempus AI with its stock at $12.22 and a very large 3 year return, alongside a 55.7% gain year to date and an 82.1% gain over the past year. The move comes after a mixed longer term picture, with the...

Ardagh Metal Packaging (AMBP) drew fresh attention after reporting second quarter 2026 results that included higher sales, improved earnings and upgraded full year Adjusted EBITDA guidance, along with a quarterly dividend announcement. See our latest analysis for Ardagh Metal Packaging. At a share price of $4.72, Ardagh Metal Packaging has a 90 day share price return of 17.71% and a 1 year total shareholder return of 34.84%. This suggests momentum has picked up recently after a weaker 5 year...

HCA Healthcare (HCA) is under scrutiny after revising its full year 2026 earnings guidance downward, citing a less favorable payer mix and more uninsured patient visits, along with a new securities fraud investigation. See our latest analysis for HCA Healthcare. At a share price of $376.50, HCA Healthcare has seen the share price fall over the past quarter and year to date, even though the 1 year total shareholder return is 11.00% and the 5 year total shareholder return is 58.38%. This...

MasTec (MTZ) is back in focus after recent results highlighted a US$20.33b backlog and strong EPS growth. This points to operational progress that has helped underpin the stock's sharp move over the past six months. See our latest analysis for MasTec. At a share price of US$358.86, MasTec has seen strong share price momentum over the longer term, with a 57.64% year to date share price return and a 97.45% 1 year total shareholder return. However, the 30 day share price return is down 8.09%,...

Futu Holdings has given investors a mixed experience, with the stock sharply down year to date yet still showing a strong 3 year return. The current Excess Returns intrinsic value estimate and market multiples both suggest the shares may be trading below what the fundamentals imply. Over the past 3 years, Futu Holdings has returned 88.9%, which keeps the longer term track record in positive territory despite recent weakness. Expectations for the company’s ability to keep converting growth...

Inspire Medical Systems stock is coming under fresh scrutiny after a steep share price decline over the past few years, while the current valuation checks send a more neutral signal, with the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples no longer flagging an obvious bargain at the latest close near US$50.81. Over the past 3 years, Inspire Medical Systems shareholders have seen the share price fall about 82%, which puts the current valuation discussion front and...

Southern Company (NYSE:SO) joined the President's Ratepayer Protection Pledge, signaling support for policies aimed at shielding customers from excessive energy costs. Georgia Power, a Southern subsidiary, entered a 25 year agreement with OpenAI to supply power to a major new data center project in Georgia. Southern, trading at $96.6, is moving deeper into power supply for AI infrastructure while publicly backing measures focused on ratepayer protection. The stock shows a return of 10.8%...

Aura Minerals (AUGO) drew investor attention after reporting operating results showing quarterly production of 75,437 gold equivalent ounces and first half output of 158,448 ounces, both above the levels reported a year earlier. See our latest analysis for Aura Minerals. The operating update comes at a time when Aura Minerals' share price has risen 10.20% year to date to US$55.10. Recent momentum has been mixed, with a 7 day share price return of 9.63% but a 90 day share price return that is...

QuantumScape (QS) is back in focus after reporting a narrower Q2 loss of $0.16 per share, paired with plans to expand its solid state battery technology into AI data centers, aerospace, and defense. See our latest analysis for QuantumScape. The latest results and expansion plans come after a weak stretch for QuantumScape’s stock, with the share price down 31.06% over the past 30 days and 53.75% year to date. The 1 year total shareholder return has declined 59.50%, suggesting sentiment has...

Aurora Innovation (AUR) has rolled out its second generation driverless trucks, using hardware built for long operating lives and higher volume production. This marks a key step toward broader commercial use on major U.S. freight routes. See our latest analysis for Aurora Innovation. Despite a sharp 1 day share price decline of around 9%, Aurora Innovation still has a 90 day share price return of 22% and a year to date share price gain of 54.78%. The 3 year total shareholder return of 119.41%...

BlackRock (NYSE:BLK) divisions reportedly took opposing positions in Aston Martin’s debt restructuring talks, creating an unusual internal conflict for the asset manager. The governance clash involves BlackRock’s bond fund unit and its HPS Investment Partners arm, which held different stakes in the carmaker’s capital structure. Separately, BlackRock joined a new consortium committing funding and support to research quantum-resistant security for Bitcoin. BlackRock is one of the largest...

SkyWest (SKYW) is back in focus after releasing second quarter 2026 results that show higher revenue than a year earlier, along with lower net income, and pairing those figures with an expanded share repurchase program. See our latest analysis for SkyWest. SkyWest's recent earnings release and expanded buyback came after a period where the share price has gained 11.79% over the past 90 days, while the 1 year total shareholder return is down 13.43%. This suggests improving short term momentum...

In late July 2026, analysts at UBS projected that Colgate-Palmolive’s Q2 results would land broadly in line with consensus, underpinned by continued momentum in its international operations and core business segments. An interesting angle for investors is how this anticipated organic sales growth abroad aligns with Colgate-Palmolive’s long-term emphasis on emerging markets and product innovation. We’ll now examine how this international-driven earnings anticipation shapes Colgate-Palmolive’s...

Lucid Group (LCID) stock is back in focus after multiple law firms highlighted ongoing securities class action lawsuits that follow alleged misstatements about deliveries, operational progress, and a supplier issue affecting Lucid Gravity production. See our latest analysis for Lucid Group. Lucid Group’s share price closed at $6.45 after a 1 day decline of 4.87%, extending a 7 day share price fall of 12.36%. This compares with a 30 day share price return of 25.24%, a year to date share price...

Aktis Oncology stock has slipped over the past month, and current valuation checks lean more expensive than cheap. This suggests the recent weakness alone does not automatically turn the shares into a clear bargain. The share price is down about 16.3% over the past month, which may tempt investors who are waiting for a better entry point. Aktis Oncology’s valuation can be heavily influenced by how reliably it converts its research pipeline into future revenue, while uncertainty around...